NCT07243743 (GLIN#5) is a NA clinical trial of First Reference Product in Glycemic Response, sponsored by Nutricia Research.

Who is sponsoring NCT07243743?

NCT07243743 is sponsored by Nutricia Research.

What drugs are being tested in NCT07243743?

Interventions in NCT07243743: First Reference Product, Second Reference Product, Third Reference Product, First Concept Product, Second Concept Product.

What condition does NCT07243743 study?

NCT07243743 studies Glycemic Response.

Is NCT07243743 still recruiting?

NCT07243743 is currently completed. Last updated 13 January 2026.

Last reviewed 2026-01-13 · How we verify

NCT07243743: GLIN#5

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of the Glycemic Responses to Nutritional Products-INQ-2526

Completed NA Last updated 13 January 2026

What this trial tests

NA trial testing First Reference Product in Glycemic Response in 14 participants. Completed in 19 November 2025.

Timeline

17 October 2025

Primary endpoint
19 November 2025

19 November 2025

Quick facts

Lead sponsor	Nutricia Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	14
Start date	17 October 2025
Primary completion	19 November 2025
Estimated completion	19 November 2025
Sites	1 location across Canada

Drugs / interventions tested

First Reference Product
Second Reference Product
Third Reference Product
First Concept Product
Second Concept Product

Conditions studied

Glycemic Response — all drugs for Glycemic Response →

Sponsor

Nutricia Research — full company profile →

Who can join

Adults 18 to 65, any sex, with Glycemic Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assesses the glycemic responses to nutritional products. During a study visit fasted subjects will consume a serving of the reference product or the test product. Capillary blood samples will be taken at baseline and at several time-points over a 2-hr period. Several nutritional products will be tested over time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Glycemic Response

Currently open trials in the same condition.

NCT04881019 — PRediction Of Glycemic RESponse Study · active not recruiting

Other Nutricia Research trials

Trials by the same sponsor.

NCT06797349 — Glin4: Assessment of the Glycemic Responses to Nutritional Products · Phase 4 · completed
NCT06920550 — A Growth Artificial Intelligence Algorithm for leNgth and Weight Study · recruiting
NCT06628024 — Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk. · NA · completed
NCT05731206 — Hypoallergenicity of a Hydrolyzed Protein Infant Formula · NA · suspended
NCT06475521 — A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07243743 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nutricia Research
Last refreshed: 13 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07243743.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing